Michele Brown was vaccinated – but had a suppressed immune system. Would better health advice have saved her?

The mother-of-two carefully shielded until the government said it was safe to see friends and family. She had no idea how her existing conditions could affect her

The feeling of relief was immense as 58-year-old Michele Brown returned home from the vaccine centre. Her husband, Terry, 61, had taken time off from his job as a supervisor at a heavy machinery factory to drive her to her second Covid-19 vaccination at a Gateshead community centre. In the car, Michele told her partner of 40 years that she felt like a weight had been lifted off her shoulders. “She said: ‘At least we’ve got that done,’” Terry remembers. “‘We’ll be OK.’”

It was 28 April 2021. Michele, who had rheumatoid arthritis, an underactive thyroid and diabetes, had spent the last year and a half shielding indoors, on government advice. She was careful. She had a Covid station set up on the breakfast counter: lateral flow tests, bottles of antibacterial gel and disposable face masks. When family came to visit, a mask-wearing Michele would banish them to the furthest corner of the living room. “We couldn’t kiss her,” remembers her daughter, Kim Brown, 41, who lives in Durham. “She would say: ‘You might have the coronies! I don’t want no coronies. You’re not giving me that crap.’”

Continue reading...

Viagra could be used to treat Alzheimer’s disease, study finds

US scientists say users of sildenafil – the generic name for Viagra – are 69% less likely to develop the form of dementia than non-users

Viagra could be a useful treatment against Alzheimer’s disease, according to a US study.

Alzheimer’s disease, the most common form of age-related dementia, affects hundreds of millions of people worldwide. Despite mounting numbers of cases, however, there is currently no effective treatment.

Continue reading...

Covid not over and next pandemic could be more lethal, says Oxford jab creator

Prof Dame Sarah Gilbert says this will not be the last time a virus threatens our lives and our livelihoods

The coronavirus pandemic that has so far killed more than 5 million people worldwide is far from over and the next one could be even more lethal, the creator of the Oxford/AstraZeneca vaccine has said.

As fears grow over the threat posed by the highly mutated Omicron variant, detected in more than 30 countries, Prof Dame Sarah Gilbert cautioned that while it was increasingly obvious that “this pandemic is not done with us”, the next one could be worse.

Continue reading...

No 10 put all their eggs in vaccine basket in effort to save Christmas

Analysis: changes to cabinet and public mood from last year make further restrictions less likely

The date ringed in red in Westminster is 18 December – not the date for Christmas parties but the time by which people should start to know how different their festive plans may look.

For this government it is quite an inauspicious date, just a day before soaring cases forced Boris Johnson to finally put the brakes on Christmas mixing plans last year and tell most families they would be spending celebrations apart.

Continue reading...

Two hippos test positive for Covid at Antwerp zoo

Staff at zoo in Belgium investigating cause of infections, which could be first reported cases in species

Two hippos at Antwerp zoo in Belgium have tested positive for Covid-19 in what could be the first reported cases in the species, staff said.

Imani, aged 14, and Hermien, 41, have no symptoms apart from runny noses, but the zoo said they had been put in quarantine as a precaution.

Continue reading...

Dealing with uncertainty about the Omicron variant | David Spiegelhalter and Anthony Masters

Caution is sensible when so much is unknown

The race is on to understand the new variant identified by scientists in South Africa and Botswana, dubbed Omicron (the next Greek letter was “nu”, but this could have been mistaken for “new”). Fears include greater spread, worse disease or reduced effectiveness of treatments and vaccines.

Increased transmission can arise from two factors. First, there is an intrinsic advantage, with a heightened “basic reproduction number” R0; in a susceptible population, that is the average number of people each case infects, although after 20 months of pandemic this has become a notional concept. It was around 3 for the original wild-type virus, compared to around 6 for Delta and possibly rather more for Omicron.

Continue reading...

Scott Morrison repeats that Australians have ‘had a gutful of governments in their lives’; Peter Cundall dies at 94 – As it happened

Gardening legend Peter Cundall dies aged 94 as PM repeats that Australians have had a ‘gutful of governments in their lives’. This blog is now closed

Hunt is asked whether states, like Queensland, will hold off opening state borders until at least 80% of kids aged five to 11 are vaccinated given today’s announcement.

Hunt:

There is no reason for that. The Doherty modelling was set out very clearly on the 80% rates for double dosed across the country for 16 plus, and what we have seen now is that in terms of the 12 to 15-year-olds, we have now had an extra 1.8 million vaccinations over and above the Doherty modelling. The Doherty modelling was based on an 80% national rate for double dosed and didn’t include 12 to 15-year-olds.

A bit over a fifth of all cases of Covid are actually in the under 12s. Indeed, some of the early data with Omicron suggests it may actually be higher for the Omicron variant ... While most kids to get fairly mild infection and only a limited number end up in ICU, is great, there are bigger impacts.

Unfortunately about one in 3,000 of the kids who get Covid actually end up with this funny immunological condition called multi-system inflammatory condition. Those kids can end up being very sick for months. It is not the same as long Covid but it has some things in common, and it has a whole range of symptoms where the kid is just not well. That is one of the things we are protecting against by vaccinating children...

Continue reading...

Omicron: what do we know about the new Covid variant?

Scientists are racing to establish the variant’s transmissibility, effect on immune system and chance of hospitalisation or death

Three major issues will determine the magnitude of the impact of the new Omicron variant of the Covid virus will have on the nation and the rest of the planet. What is the transmissibility of this new Covid variant? How good is it at evading the antibodies and T-cells that make up a person’s immune defences? What are the chances it will trigger severe illness that could lead to the hospitalisation, and possibly death, of an infected person.

Scientists are struggling to find definitive answers to these critically important questions, although evidence already suggests Omicron has the potential to cause serious disruption. “The situation is very finely tuned and could go in many different directions,” says Prof Rowland Kao of Edinburgh University.

Continue reading...

Covid antiviral pill molnupiravir/Lagevrio set for UK at-home trials

People most vulnerable to Omicron would reportedly be offered experimental pill within 48 hours of testing positive

The first at-home treatment for Covid-19 could reportedly be offered to UK patients before Christmas as an attempt to protect the most vulnerable from the Omicron variant.

The Sunday Telegraph reported that Sajid Javid is set to launch a national pilot of the Molnupiravir antiviral pill, marketed as Lagevrio.

Continue reading...

UK’s progress on Covid now squandered, warns top scientist

Sir Jeremy Farrar, director of Wellcome Trust, suggests emergence of Omicron variant means pandemic is far from over

The emergence of the Omicron variant shows that the world is “closer to the start of the pandemic than the end”, one of Britain’s most senior scientific figures has warned, as he lamented a lack of political leadership over Covid.

Sir Jeremy Farrar, the director of the Wellcome Trust who stepped down as a government scientific adviser last month, said the progress in combatting Covid-19 since its emergence was “being squandered”.

Continue reading...

Omicron proves we’re not in control of Covid – only global action can stop this pandemic

If we keep allowing this virus to spread through unvaccinated populations, the next variant could be even more deadly

It’s almost two years since we first heard of Covid-19, and a year since the first Covid vaccines were rolled out. Yet this staggering progress is being squandered. We have drifted for months now, with richer countries, taking a very blinkered domestic focus, lulled into thinking that the worst of the pandemic was behind us. This variant reminds us all that we remain closer to the start of the pandemic than the end.

There is a lot we need to learn about the Omicron variant. Whether or not this is a pandemic-changing variant – one that really evades our vaccines and treatments – remains to be seen. Research will tell us more in the coming days and weeks, and we must watch and follow the data closely while giving the brilliant scientific teams time to get the answers. Although I am very worried about countries with limited access to vaccines, I am cautiously hopeful that our current vaccines will continue to protect us against severe sickness and death, if we are fully vaccinated.

Continue reading...

Omicron cases climb amid Sydney cluster; Qld to quarantine Adelaide travellers – as it happened

South Australia announces rule changes for interstate arrivals as ACT records first case of variant. This blog is now closed

Just noting we are still waiting on the SA press conference to begin.

There’s a press conference with the South Australian premier, Steven Marshall, and CHO Nicola Spurrier at 9.45am SA time (so roughly half an hour from now).

Continue reading...

Does the Omicron variant mean Covid is going to become more transmissible?

As new strain dampens idea pandemic might be diminishing, what does the future hold for coronavirus?

When scientists predicted, months ago, that Covid-19 could be entering an endemic phase, many felt ready for the crisis period of the pandemic to be over. The tantalising suggestion that coronavirus might, at some foreseeable point, be just another seasonal cold felt welcome. But the emergence of the Omicron variant, just weeks before Christmas, shows this is not guaranteed to be a smooth or quick transition.

Continue reading...

Covid booster shots significantly strengthen immunity, trial finds

Jabs offer far higher protection than that needed to prevent hospitalisation and death, Cov-Boost trial lead says

Covid booster shots can dramatically strengthen the body’s immune defences, according to a study that raises hopes of preventing another wave of severe disease driven by the Omicron variant.

In a study published in the Lancet, researchers on the UK-based Cov-Boost trial measured immune responses in nearly 3,000 people who received one of seven Covid-19 boosters or a control jab two to three months after their second dose of either AstraZeneca or Pfizer vaccine.

Continue reading...

How probable is it Omicron Covid variant will take hold in UK?

Analysis: UK’s early vaccine deployment and use of different vaccines from South Africa mean it’s too soon to say

Omicron is causing consternation around the world, with the variant found to be behind an exponential rise in Covid cases in South Africa. Yet with just 42 cases confirmed in the UK so far, and most European countries seeing numbers in the double rather than triple figures, could this be a tentative sign the variant may fail to take hold outside southern Africa? The bottom line is, it is too soon to say.

One issue is that there are important differences that make it difficult to compare the situations in South Africa and beyond.

Continue reading...

Covid: scientists find possible trigger for AstraZeneca jab blood clots

Experts hope better understanding of rare side effect of vaccine could help ‘turn the tide’ on pandemic

Scientists believe they may have found the trigger behind the extremely rare blood clot complications stemming from the Oxford/AstraZeneca’s Covid vaccine.

According to a team of researchers from Cardiff and the US, the reaction can be traced to the way the adenovirus used by the vaccine to shuttle the coronavirus’s genetic material into cells binds with a specific protein in the blood, known as platelet factor 4 (PF4).

Continue reading...

Covid limits migration despite more people displaced by war and disasters

IOM report finds 9m more people displaced globally but mobility restricted due to pandemic, with vaccination proving a key factor


The coronavirus pandemic had a radical effect on migration, limiting movement despite increasing levels of internal displacement from conflict and climate disasters, the UN’s International Organization for Migration said in a report on Wednesday.

Though the number of people who migrated internationally increased to 281 million in 2020 – 9 million more than before Covid-19 – the number was 2 million lower than expected without a pandemic, according to the report.

Continue reading...

Covid-19 variants may not evolve to be less dangerous, says Neil Ferguson

Senior UK scientist says extent of threat posed by Omicron will not be clear until end of year

People should not assume that Covid will evolve to become a milder disease, a senior scientist has warned, adding that the threat posed by the Omicron coronavirus variant will not be clear until the end of December.

Prof Neil Ferguson, head of the disease outbreak analysis and modelling group at Imperial College London, told MPs on Wednesday that while evolution would drive Covid to spread more easily the virus might not become less dangerous.

Continue reading...

When did Omicron Covid variant arrive in UK and is it spreading?

Analysis: scientists are working full tilt to answer these vital questions that may give clues as to what is to come

As new cases of Omicron continue to emerge in the UK, scientists are working full tilt to answer two vital questions: when did the variant arrive and is it spreading?

While at first glance those queries may seem less important than those around vaccine effectiveness or disease severity, the answers may give important clues as to what is to come.

Continue reading...

Omicron Covid variant ‘present in Europe at least 10 days ago’

Two cases of new Covid variant found in Netherlands predate last week’s alert from South Africa

The Omicron variant of Covid-19 was present in Europe at least 10 days ago and already appears to be spreading in the Netherlands and elsewhere.

“We have found the Omicron coronavirus variant in two test samples that were taken on November 19 and 23,” the Dutch health ministry said in a statement on Tuesday. “It is not yet clear whether these people had also visited southern Africa,” the ministry added.

Continue reading...